FERMENTA.BO BSE
Fermenta Biotech Ltd.
1W: +14.5%
1M: +14.1%
3M: +59.5%
YTD: +77.7%
1Y: +53.3%
3Y: +261.3%
5Y: +82.5%
₹560.00 ($5.81)
+8.65 (+1.57%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$4.7B
+40.8% ▲
5Y CAGR: +10.5%
Gross Profit
$3.2B
+372.8% ▲
5Y CAGR: +24.5%
Operating Income
$856M
+2178.0% ▲
5Y CAGR: +14.0%
Net Income
$769M
+433.3% ▲
5Y CAGR: +5.2%
EPS (Diluted)
$26.47
+431.3% ▲
5Y CAGR: +5.1%
EBITDA
$1.2B
+295.0% ▲
5Y CAGR: +9.1%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $3.7B | $4.0B | $3.5B | $3.3B | $4.7B |
| YoY Growth | +30.1% | +7.1% | -12.3% | -4.5% | +40.8% |
| Cost of Revenue | $1.4B | $3.0B | $2.9B | $1.5B | $1.5B |
| Gross Profit | $1.1B | $995M | $613M | $681M | $3.2B |
| Gross Margin | 30.6% | 25.0% | 17.6% | 20.4% | 68.6% |
| R&D Expenses | $56M | $82M | $134M | $133M | $120M |
| SG&A Expenses | $606M | $514M | $296M | $621M | $324M |
| Operating Expenses | $554M | $629M | $684M | $754M | $2.4B |
| Operating Income | $1.7B | $369M | -$71M | $38M | $856M |
| Operating Margin | 45.0% | 9.3% | -2.0% | 1.1% | 18.2% |
| Interest Expense | $190M | $180M | $214M | $174M | $142M |
| Income Before Tax | $516M | $269M | -$513M | -$99M | $832M |
| Tax Expense | $91M | $119M | $18M | $141M | $68M |
| Net Income | $455M | $154M | -$511M | -$231M | $769M |
| Net Margin | 12.2% | 3.9% | -14.6% | -6.9% | 16.4% |
| EPS (Diluted) | $15.69 | $5.33 | $-17.70 | $-7.99 | $26.47 |
| EBITDA | $876M | $705M | -$17M | $308M | $1.2B |
| Shares Outstanding | 29M | 29M | 29M | 29M | 29M |